GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Conceptus, Inc. (CPTS) [hlAlert]

Conceptus, Inc. develops, manufactures and markets the Essure permanent birth control system, a medical device for women that is approved for marketing in the United States by the United States Food and Drug Administration (FDA). The Essure system uses a soft
and flexible micro-insert that is delivered into a woman's fallopian tubes to provide permanent birth control by causing benign tissue in-growth that blocks the fallopian tubes. A properly placed Essure micro-insert and the subsequent tissue growth prohibits the egg from traveling through the fallopian tubes and therefore prevents fertilization. On January 7, 2008, the Company acquired all of the outstanding shares of Conceptus SAS. Through Conceptus SAS, it sells Essure directly in France and uses distributors to sell Essure throughout the rest of Europe.
.
( Total: 20 Current Stock Recommendations )
Conceptus, Inc.   (20)
Sell Hold 65% Buy 30%
Related companies
Zoll Medical ...   (7)
Buy 100%
Endologix Inc   (9)
Buy 100%
Msa Safety Inc.   (6)
Hold 17% Buy 83%
Smith & Nephew ...   (21)
Sell Hold 38% Buy 48%
Sonosite, Inc.   (4)
Hold 50% Buy 50%
Steris Corporation   (9)
Hold 33% Buy 67%
Synovis Life ...   (4)
Sell 25% Hold 50% Buy 25%
Wright Medical ...   (20)
Hold 45% Buy 55%
Ev3 Inc.   (15)
Hold 53% Buy 47%
Volcano Corporation   (24)
Hold 46% Buy 54%
Filter by Gains:   
  
Rating:
Hold CPTS
Conceptus, Inc. (CPTS) rated Mkt Perform by Raymond James
Wednesday,  May 29, 2013  8:25 AM ET

Rating:
Hold CPTS
up 37.40 %

Rating:
Hold CPTS
Conceptus, Inc. (CPTS) rated Hold by Craig Hallum
Tuesday,  Apr 30, 2013  9:25 AM ET

Rating:
Hold CPTS
up 57.35 %

Rating:
Buy CPTS
up 37.40 %
Conceptus, Inc. (CPTS) upgraded to Buy by Summer Street Research
Wednesday,  Mar 6, 2013  10:25 AM ET

Rating:
Buy CPTS
up 39.04 %

Rating:
Hold CPTS
Conceptus, Inc. (CPTS) rated Neutral by Sun Trust Rbsn Humphrey
Friday,  Nov 16, 2012  8:25 AM ET

Rating:
Hold CPTS
Conceptus, Inc. (CPTS) rated Neutral by Piper Jaffray
Monday,  Jul 30, 2012  8:25 AM ET

Rating:
Buy CPTS
up 57.35 %

Rating:
Hold CPTS

Rating:
Hold CPTS

Rating:
Hold CPTS

Rating:
Hold CPTS
Conceptus, Inc. (CPTS) rated Neutral by Summer Street Research
Tuesday,  Aug 2, 2011  10:25 AM ET

Rating:
Hold CPTS

Rating:
Buy CPTS
up 137.70 %
Conceptus, Inc. (CPTS) rated Buy by GARP Research
Friday,  May 13, 2011  9:25 AM ET

Your Recent Stocks
SymbolLastChange
CPTS 31.02   0.00 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy